Informações:
Falhas:
ID
38490
Descrição
Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen; ODM derived from: https://clinicaltrials.gov/show/NCT01850147
Link
https://clinicaltrials.gov/show/NCT01850147
Palavras-chave
Versões (1)
- 22/10/2019 22/10/2019 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
22 de outubro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Cancer NCT01850147
Eligibility Cancer NCT01850147
- StudyEvent: Eligibility
Similar models
Eligibility Cancer NCT01850147
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Non-Small Cell Lung Carcinoma TNM clinical staging
Item
histologic or cytologic diagnosis of stage iiib/iv nsclc
boolean
C0007131 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,2])
ECOG performance status
Item
ecog ps: 0,1
boolean
C1520224 (UMLS CUI [1])
Measurable Disease Linear | Measurable Disease 2-Dimensional
Item
unidimensional or bi-dimensional measurable disease
boolean
C1513041 (UMLS CUI [1,1])
C0205132 (UMLS CUI [1,2])
C1513041 (UMLS CUI [2,1])
C1705052 (UMLS CUI [2,2])
C0205132 (UMLS CUI [1,2])
C1513041 (UMLS CUI [2,1])
C1705052 (UMLS CUI [2,2])
First line Chemotherapy Platinum-Based | Second line Chemotherapy | EGFR inhibitor Quantity
Item
receive prior treatment including first-line platinum-based chemotherapy, standard second-line chemotherapy and 1 egf/egfr inhibitor
boolean
C1708063 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C1514162 (UMLS CUI [1,3])
C1710038 (UMLS CUI [2,1])
C0392920 (UMLS CUI [2,2])
C1443775 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0392920 (UMLS CUI [1,2])
C1514162 (UMLS CUI [1,3])
C1710038 (UMLS CUI [2,1])
C0392920 (UMLS CUI [2,2])
C1443775 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
Disease Progression
Item
evidence of disease progression
boolean
C0242656 (UMLS CUI [1])
Life Expectancy
Item
life expectancy >12 weeks
boolean
C0023671 (UMLS CUI [1])
Neutrophil count | Platelet Count measurement | Hemoglobin measurement | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Alkaline phosphatase measurement | Creatinine measurement, serum
Item
neutrophils > 1.5 109/l, platelets > 100 109/l, hemoglobin > 9g/dl, total bilirubin < 1.5 unl, ast (sgot) and alt (sgpt) < 2.5 unl, alkaline phosphatases < 5 unl, creatinine < 1 unl
boolean
C0200633 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
C1278039 (UMLS CUI [4])
C0201899 (UMLS CUI [5])
C0201836 (UMLS CUI [6])
C0201850 (UMLS CUI [7])
C0201976 (UMLS CUI [8])
C0032181 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
C1278039 (UMLS CUI [4])
C0201899 (UMLS CUI [5])
C0201836 (UMLS CUI [6])
C0201850 (UMLS CUI [7])
C0201976 (UMLS CUI [8])
Hemoptysis Pre-existing CTCAE Grades
Item
pre-existing hemoptysis of a severity > grade 3 by nci ctcae criteria within 4 weeks prior to study entry
boolean
C0019079 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
C2347662 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
Uncontrolled hypertension
Item
uncontrolled hypertension
boolean
C1868885 (UMLS CUI [1])
Congestive heart failure | Angina Pectoris | Cardiac Arrhythmia
Item
chf, angina or arrhythmias
boolean
C0018802 (UMLS CUI [1])
C0002962 (UMLS CUI [2])
C0003811 (UMLS CUI [3])
C0002962 (UMLS CUI [2])
C0003811 (UMLS CUI [3])
Left ventricular ejection fraction
Item
lvef < 1 unl
boolean
C0428772 (UMLS CUI [1])
Second Primary Cancer
Item
existing a second malignancy within 5 years
boolean
C0751623 (UMLS CUI [1])
HIV Infection
Item
infected with hiv
boolean
C0019693 (UMLS CUI [1])